Detalhe da pesquisa
1.
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.
J Med Internet Res
; 26: e49910, 2024 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696248
2.
Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study.
Br J Cancer
; 129(11): 1780-1786, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813959
3.
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Cancer
; 128(21): 3775-3783, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36101004
4.
Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Pediatr Blood Cancer
; 69(3): e29403, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636137
5.
Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.
Pediatr Blood Cancer
; 69(1): e29316, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546642
6.
Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults.
Pediatr Blood Cancer
; 69(9): e29691, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441463
7.
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS).
Pediatr Blood Cancer
; 68(10): e29145, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089219
8.
The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children.
Pediatr Blood Cancer
; 68 Suppl 4: e29072, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913610
9.
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Pediatr Blood Cancer
; 68(3): e28794, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205902
10.
Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
J Surg Oncol
; 122(7): 1337-1347, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812260
11.
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 67(8): e28359, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472746
12.
Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Pediatr Blood Cancer
; 67(2): e28009, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736251
13.
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Clin Orthop Relat Res
; 478(2): 290-302, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580267
14.
Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Pediatr Blood Cancer
; 66(9): e27879, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215116
15.
Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Pediatr Blood Cancer
; 66(6): e27652, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30762282
16.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1617-1629, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442501
17.
Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.
Int J Cancer
; 142(2): 297-307, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28921546
18.
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.
Br J Cancer
; 118(11): 1502-1512, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755120
19.
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
Eur J Nucl Med Mol Imaging
; 45(2): 292-305, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940046
20.
Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Pediatr Blood Cancer
; 65(12): e27405, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124238